-55% on Q3-14 SPP some erosion. Happy not my lot Very promising biotech SP struggling going on 12 mos. w/ min + 12 mos to prelim STEP or cancer vaccine results.
Understand biotech not FIN....like CBA. No forcing a patience game, but $ runway to CT results not paved w/ patience. Co lists 6 not 2 products. And HiQCell(?) Almost no solid comms than Progenza & RGSH4K for long time. KVax? Sec cream? Cryoshot? No news?
Caution after Q3-14 ABC good tho agree w/ znew-lack of co comms full stop ongoing problem. Much weighing down SP IMHO. Would not expect changed story now from May 25th ABC report. ABC..how ironic.
Working hard to raise profile positive-& needed. Even Bruce Dazzling biotechs need consistent careful comms & marketing & solid news helps.
FB not main co comms route, but page w/ last post Q3-14........
On positive-co lifts comms & profile game & net income & some solid news & Q3-14 SPP subscribers likely to see some light & top up sweepers smiling.
RGS Price at posting:
12.5¢ Sentiment: Hold Disclosure: Held
Very promising biotech SP struggling going on 12 mos. w/ min + 12 mos to prelim STEP or cancer vaccine results.
